目的:探讨成人麻疹的流行病学与临床特征。方法:回顾性分析196例成人麻疹的临床资料。结果:患者以外来流动人员及本地农村人口多见,平均年龄26.78岁,多数患者未接种麻疹疫苗或麻疹疫苗史不详。成人麻疹患者临床症状重,皮疹典型,为充血性斑丘疹,麻疹黏膜斑(Koplik’s spots)明显,且持续时间长,可合并肝脏和心肌损伤,但并发症以肺炎和支气管炎为主。结论:有必要加强成人的免疫接种,尤其是外来的务工人员,强化医务人员对麻疹的认识,避免麻疹的流行。
Objectives To evaluate the efficacy and safety of desloratadine in the patients with chronic urticaria(cu). Methods We searched PubMed, Blackwell, BIOSIS Preview, The Cochrane Library, VIP and CNKI electronically from January 1, 2000 to April, 2008. Relevant journals and conference proceedings were also handsearched. Randomized controlled trials (RCTs) and quasi-RCTs comparing desloratadine with other medicines in the patients with CIU were considered eligible. The quality of the included trials was assessed by the Jadad scale, and meta-analysis was conducted using RevMan 5.0 software. Results Nineteen trials involving 3,448 participants contributed to the meta-analysis. The results of the meta-analysis indicated that desloratadine showed similar effect on the improvement of signs and symptoms compared with loratadine RR 1.04 and 95%CI 0.99 to 1.09, mizolastine in RR 0.99 and 95%CI 0.92 to 1.07, cetirizine RR 1.05 and 95%CI 0.97 to 1.13 and terfenadine RR 1.10 and 95%CI 0.84 to 1.44. And desloratadine had similar safety to mizolastine RR 0.84 and 95%CI 0.45 to 1.58, ceririzine RR 0.67 and 95%CI 0.67 and 0.39 to 1.15 and terfenadine RR 0.44 and 95%CI 0.17 to 1.10. Desloratadine was safer than loratadine RR 0.74 and 95%CI 0.55 to 1.00. Conclusions Desloratadine, the active metabolite of loratadine, is an oral, once-daily, non-sedating antihistamine that is effective in the treatment of CIU. Desloratadine provides rapid and sustained relief of CIU symptoms.
ObjectiveTo investigate the relationship between mycoplasma pneumonia infection (MP) and acute urticaria (AU). MethodsFrom December 2011 to November 2012, in the department of clinical laboratory of the Lishui Central Hospital, the blood samples of 178 patients with acute urticaria (group AU) and 200 healthy volunteers (group C) who initially visited this hospital were collected to detect the MP-IgM+IgG+IgA antibody in the serum. The occurrence of positive MP antibody was recorded and the positive rate was calculated. ResultsCompared with group C, the incidence of positive MP was significantly increased in group AU (P < 0.01). ConclusionMycoplasma pneumoniae infection may be one of the causes of acute urticaria.
ObjectiveTo systematically review the association between dehydroepiandrosterone-sulfate (DHEA-S) and chronic urticarial (CU). MethodsWe searched databases including The Cochrane Library (Issue 3, 2015), PubMed, EMbase, CBM, VIP, CNKI and WanFang Data from inception to January 2016, to collect case-control studies about the association between DHEA-S and CU. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Meta-analysis was performed by using RevMan 5.3 software. ResultsA total of 8 papers involving 9 case-control studies were included. The results of meta-analysis showed that DHEA-S might be associated with CU (SMD=-0.93, 95%CI -1.35 to -0.50, P<0.000 01). Subgroup analysis by the difference of measuring methods, indicated that DHEA-S might be associated with CU (ECLIA: SMD=-0.75, 95% CI -1.08 to -0.42, P<0.000 01; ELISA: SMD=-0.59, 95% CI -0.87 to -0.31, P<0.000 1; EIA: SMD=-2. 70, 95% CI -3.30 to -2.10, P<0.000 01). Sensitivity analysis showed that our results were reliable and stable. ConclusionThe meta-analysis suggests that DHEA-S might be associated with CU. Due to the limited quality and quantity of included studies, more high quality studies are needed to verify the above conclusion.